238 related articles for article (PubMed ID: 7540792)
1. Ex vivo expansion of umbilical cord blood hematopoietic progenitor cells by combinations of cytokines.
Urashima M; Hoshi Y; Akiyama M; Kamijo M; Kato Y; Akatsuka J; Maekawa K; Matsuzaki M; Ohnishi J; Kaihara C
Acta Paediatr Jpn; 1995 Apr; 37(2):160-5. PubMed ID: 7540792
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.
Brugger W; Möcklin W; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
Blood; 1993 May; 81(10):2579-84. PubMed ID: 7683923
[TBL] [Abstract][Full Text] [Related]
3. Cocultivation of umbilical cord blood cells with endothelial cells leads to extensive amplification of competent CD34+CD38- cells.
Rosler E; Brandt J; Chute J; Hoffman R
Exp Hematol; 2000 Jul; 28(7):841-52. PubMed ID: 10907646
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo expansion of CD34 + CD38- cord blood cells.
De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; De Hemptinne D; Stryckmans P
J Hematother; 1997 Apr; 6(2):93-102. PubMed ID: 9131438
[TBL] [Abstract][Full Text] [Related]
5. FLT3 ligand preserves the uncommitted CD34+CD38- progenitor cells during cytokine prestimulation for retroviral transduction.
Nielsen SD; Husemoen LL; Sørensen TU; Gram GJ; Hansen JE
J Hematother Stem Cell Res; 2000 Oct; 9(5):695-701. PubMed ID: 11091493
[TBL] [Abstract][Full Text] [Related]
6. Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media.
Shaw PH; Olszewski M; Kletzel M
J Hematother Stem Cell Res; 2001 Jun; 10(3):391-403. PubMed ID: 11454314
[TBL] [Abstract][Full Text] [Related]
7. The activity in ex vivo expansion of cord blood myeloid progenitor cells before and after cryopreservation.
Wang SY; Hsu ML; Huang MZ; Hsu HC; Tzeng CH; Hung JH; Ho CK
Acta Haematol; 2001; 105(1):38-44. PubMed ID: 11340252
[TBL] [Abstract][Full Text] [Related]
8. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
[TBL] [Abstract][Full Text] [Related]
9. Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function.
Dorrell C; Gan OI; Pereira DS; Hawley RG; Dick JE
Blood; 2000 Jan; 95(1):102-10. PubMed ID: 10607692
[TBL] [Abstract][Full Text] [Related]
10. Stromal support augments extended long-term ex vivo expansion of hemopoietic progenitor cells.
Kusadasi N; Koevoet JL; van Soest PL; Ploemacher RE
Leukemia; 2001 Sep; 15(9):1347-58. PubMed ID: 11516095
[TBL] [Abstract][Full Text] [Related]
11. CD34+CD38- is a good predictive marker of cloning ability and expansion potential of CD34+ cord blood cells.
Encabo A; Mateu E; Carbonell-Uberos F; Miñana MD
Transfusion; 2003 Mar; 43(3):383-9. PubMed ID: 12675725
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the cell cycle status and primitive cell adhesion molecule profile of human CD34+ cells cultured in stroma-free versus porcine microvascular endothelial cell cultures.
Chute JP; Saini AA; Kampen RL; Wells MR; Davis TA
Exp Hematol; 1999 Feb; 27(2):370-9. PubMed ID: 10029177
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
[TBL] [Abstract][Full Text] [Related]
14. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
Peled T; Mandel J; Goudsmid RN; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall EJ; Nagler A
Cytotherapy; 2004; 6(4):344-55. PubMed ID: 16146887
[TBL] [Abstract][Full Text] [Related]
15. Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood.
Bari S; Chu PP; Lim A; Fan X; Gay FP; Bunte RM; Lim TK; Li S; Chiu GN; Hwang WY
Nanomedicine; 2013 Nov; 9(8):1304-16. PubMed ID: 23732300
[TBL] [Abstract][Full Text] [Related]
16. CD34++ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source.
Weekx SF; Van Bockstaele DR; Plum J; Moulijn A; Rodrigus I; Lardon F; De Smedt M; Nijs G; Lenjou M; Loquet P; Berneman ZN; Snoeck HW
Exp Hematol; 1998 Oct; 26(11):1034-42. PubMed ID: 9766443
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
18. Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin.
Petzer AL; Zandstra PW; Piret JM; Eaves CJ
J Exp Med; 1996 Jun; 183(6):2551-8. PubMed ID: 8676076
[TBL] [Abstract][Full Text] [Related]
19. IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood vs. adult bone marrow.
van de Ven C; Ishizawa L; Law P; Cairo MS
Exp Hematol; 1995 Nov; 23(12):1289-95. PubMed ID: 7589284
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
